Transgenic organisms
Conducting research using transgenic organisms is one of the most important innovative segments associated with the biotechnology market.
09.11.2022Conducting research using transgenic organisms is one of the most important innovative segments associated with the biotechnology market.
09.11.2022The anti—aging race is led by four companies from the United States, the first country in the world to allow testing anti-aging drugs on humans.
02.09.2022Thorough analysis of market dynamics, business models, segment/regional analysis, as well as market shares and strategies.
22.02.2022The global biotechnology market is estimated to grow from US$ 505.2 billion in 2020 to US$ 762.4 billion in 2027.
22.02.2022The domestic market of genetic tests will grow by an average of 15% per year and will reach 5 billion rubles by 2025.
02.02.2022Maxim Reliable, an expert in the field of investments, analyzed the advantages and risks of the most promising biotechnological industries.
09.11.2021The cure for old age will bring the creators a huge profit, but skeptics believe that they will find it very soon.
06.09.2021Investors are increasing investments in technologies based on the achievements of genomics, metabolomics, transcriptomics and other "omics".
26.08.2021According to analysts' forecasts, the personalized medicine market will grow by 6.2% by 2028, including at the expense of the pharmaceutical sector.
06.07.2021The president of the company Longevica Alexander Chikunov – about his experiments on the search for life-prolonging drugs.
18.05.2021Forecast of the development of the longevity and anti-aging therapy market, key opportunities and analysis of the leading players until 2028.
19.02.2021About 47% of Russians aged 16 to 40 are already ready to diversify their protein diet with plant-based meat.
01.02.2021Companies that are engaged in real projects, no more than 2% in this field, and the remaining 98%, unfortunately, are mostly scammers.
22.12.2020Of particular interest to investors in the field of medicine are two areas: the introduction of IT solutions in the work of doctors and the development of genetics.
27.11.2020This year, many startups have entered the market that are not related to the coronavirus, but this does not lose relevance.
26.11.2020Some experts believe that investors should not bet on winners and losers in the race to develop a coronavirus vaccine.
21.10.2020Egor Abramov, Investment Director of the Fort Ross Venture Fund – about the current state of the venture market in Russia.
14.10.2020Startups have attracted more than 50 million rubles of investments: the results of the biomedical track of the Moscow Accelerator have been summed up.
09.10.2020Recommendations of Rospotrebnadzor for employers on the prevention of coronavirus infection in the workplace.
29.09.2020If you haven't had time to invest in one of the companies developing the coronavirus vaccine, it's not too late to do it now.
01.09.2020You can write to the editor at:
vm@vechnayamolodost.ruThe editors of Eternal Youth are preparing a useful and interesting mailing list. You can get it if you leave your mail.